No retraction, correction or concern found when last checked on Oct 17, 2026.

COVID-19 pneumonia: ARDS or not?

Luciano Gattinoni, Davide Chiumello, Sandra Rossi

Critical Care · 2020 · CC BY

Abstract

@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) { button{line-height:inherit}html,label{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif}html{-webkit-font-smoothing:subpixel-antialiased;box-sizing:border-box;color:#333;font-size:100%;height:100%;line-height:1.61803;overflow-y:scroll}*{box-sizing:inherit}body{background:#fff;margin:0;max-width:100%;min-height:100%}button,div,form,input{margin:0;padding:0}body,p{padding:0}a{color:#004b83;text-decoration:underline;text-decoration-skip-ink:auto}a>img{vertical-align:middle}h1,h2,h3{margin-top:0}h1{font-size:28px;font-weight:700}html.webfonts-loaded h1,html.webfonts-loaded h2,html.webfonts-loaded h3{font-family:Europa,Trebuchet MS}h1,h2,h3{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-style:normal;line-height:1.4}h2{font-size:26px;font-weight:700;margin-bottom:.5em}h3{font-size:18px;margin-bottom:.7em}p{margin:0}ul{margin-top:0}p{margin-bottom:1.5em}p:last-child{margin-bottom:0}p:empty{display:none}.c-ad{text-align:center}@media only screen and (min-width:320px){.c-ad{padding:8px}}.c-ad--728x90{background-color:#ccc;display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}.c-ad--728x90 iframe{height:90px;max-width:970px}@media only screen and (min-width:768px){.js .c-ad--728x90{display:none}.js .u-show-following-ad+.c-ad--728x90{display:block}}.c-ad--300x250{background-color:#f2f2f2;display:none;padding:8px}.c-ad--300x250 .c-ad__inner{min-height:calc(1.5em + 254px)}@media only screen and (min-width:320px){.js .c-ad--300x250{display:block}}.c-ad iframe{border:0;overflow:auto;vertical-align:top}.c-ad__label{color:#333;font-weight:400;line-height:1.5;margin-bottom:4px}.c-ad__label,.c-skip-link{font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:.875rem}.c-skip-link{background:#dceaf6;bottom:auto;color:#004b83;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:link{color:#004b83}.c-dropdown__button:after{border-color:transparent transparent transparent #fff;border-style:solid;border-width:4px 0 4px 14px;content:"";display:block;height:0;margin-left:3px;width:0}.c-dropdown{display:inline-block;position:relative}.c-dropdown__button{background-color:transparent;border:0;display:inline-block;padding:0;white-space:nowrap}.c-dropdown__button:after{border-color:currentcolor transparent transparent;border-width:5px 4px 0 5px;display:inline-block;margin-left:8px;vertical-align:middle}.c-dropdown__menu{background-color:#fff;border:1px solid #d9d9d9;border-radius:3px;box-shadow:0 2px 6px rgba(0,0,0,.1);font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.4;list-style:none;margin:0;padding:8px 0;position:absolute;top:100%;transform:translateY(8px);width:180px;z-index:100}.c-dropdown__menu:after,.c-dropdown__menu:before{border-style:solid;bottom:100%;content:"";display:block;height:0;left:16px;position:absolute;width:0}.c-dropdown__menu:before{border-color:transparent transparent #d9d9d9;border-width:0 9px 9px;transform:translateX(-1px)}.c-dropdown__menu:after{border-color:transparent transparent #fff;border-width:0 8px 8px}.c-dropdown__menu--right{left:auto;right:0}.c-dropdown__menu--right:after,.c-dropdown__menu--right:before{left:auto;right:16px}.c-dropdown__menu--right:before{transform:translateX(1px)}.c-dropdown__link{background-color:transparent;color:#004b83;display:block;padding:4px 16px;text-decoration:none}.c-header{background-color:#1b3051;border-bottom:4px solid #1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;padding:16px 0}.c-header__container,.c-header__menu{align-items:center;display:flex;flex-wrap:wrap}@supports (gap:2em){.c-header__container,.c-header__menu{gap:2em 2em}}.c-header__menu{list-style:none;margin:0;padding:0}.c-header__item{color:#fff}@supports not (gap:2em){.c-header__item{margin-left:24px}}.c-header__container{justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}@supports not (gap:2em){.c-header__brand{margin-right:48px}}.c-header__brand a{display:block;text-decoration:none}.c-header__link{color:#fff}.c-header__link,.c-journal-title a{text-decoration:none}html.webfonts-loaded .c-journal-title{font-family:Europa,Trebuchet MS}.c-form-field{margin-bottom:1em}.c-form-field__label{color:#666;display:block;font-size:14px;margin-bottom:.4em}.c-form-field__input{border:1px solid #a6a6a6;border-radius:3px;box-shadow:inset 0 1px 3px 0 rgba(0,0,0,.21);font-size:14px;line-height:1.28571;padding:.75em 1em;vertical-align:middle;width:100%}.c-popup-search{background-color:#25426f;box-shadow:0 3px 3px -3px rgba(0,0,0,.21);padding:16px 0;position:relative;z-index:10}@media only screen and (min-width:1024px){.js .c-popup-search{position:absolute;top:100%;width:100%}.c-popup-search__container{margin:auto;max-width:70%}}.c-logo img{display:block}.ctx-search .c-form-field{margin-bottom:0}.ctx-search .c-form-field__label{color:#fff}.ctx-search .c-form-field__input{border-bottom-right-radius:0;border-top-right-radius:0;margin-right:0}.c-journal-header{overflow:hidden}.c-journal-header__inner{padding-bottom:8px;padding-top:8px}@media only screen and (min-width:540px){.c-journal-header__inner{display:flex;justify-content:space-between}}.c-journal-header__identity{background-size:auto 80px;min-height:16px;padding:6px 0}@media only screen and (min-width:540px){.c-journal-header__identity{background-position:0}}.c-journal-header__identity--default{background:url(/static/images/bmc/identities/patterns/default-7e3a6b1388.svg) 0 0 no-repeat #04caa8}.c-journal-title{color:#1b3051;display:flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:26px;font-style:normal;font-weight:700;line-height:1.4;margin-bottom:0}.c-journal-title>a{color:#0097ef;color:#1b3051;display:flex;text-decoration:none}.c-journal-title__text{align-self:center;display:block;flex:0 1 auto}.c-logo,.c-logo>a{align-items:baseline;display:flex}.c-logo__strapline{display:none}@media only screen and (min-width:540px){.c-logo__strapline{display:block;margin:0 0 0 16px;transform:translateY(1px)}}.c-navbar{background:#f2f2f2;border-bottom:1px solid #d9d9d9;border-top:1px solid #d9d9d9;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:14px;line-height:1.42857;padding:16px 0}.c-navbar__container{align-items:center;display:flex;flex-wrap:wrap;justify-content:space-between;margin:0 auto;max-width:1280px;padding:0 16px}.c-navbar__content{align-items:center;display:flex;flex:0 1 auto}@media only screen and (min-width:1024px){.c-navbar__content{display:flex!important}}.c-navbar__nav{display:flex;list-style:none;margin:0;padding:0}@media only screen and (min-width:1024px){.c-navbar__nav{transform:translateY(1px)}}.c-navbar__item{flex:1 0 auto}@media only screen and (max-width:539px){.c-navbar__item{font-size:.75rem}}.c-navbar__item:not(:first-child){margin-left:16px}.c-navbar__link{background:0 0;border:0;color:currentcolor;display:block;text-decoration:none;text-transform:capitalize}.c-navbar__link--is-shown{text-decoration:underline}.c-logo{display:block}html.webfonts-loaded .u-h3,html.webfonts-loaded .u-h4{font-family:Europa,Trebuchet MS}.u-button{align-items:center;background-color:#f2f2f2;background-image:linear-gradient(#fff,#f2f2f2);border:1px solid #ccc;border-radius:2px;cursor:pointer;display:inline-flex;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:1rem;justify-content:center;line-height:1.3;margin:0;padding:8px;position:relative;text-decoration:none;transition:all .25s ease 0s,color .25s ease 0s,border-color .25s ease 0s;width:auto}.u-button svg,.u-button--primary svg{fill:currentcolor}.u-button{color:#004b83}.u-button--primary{background-color:#33629d;background-image:linear-gradient(#4d76a9,#33629d);border:1px solid rgba(0,59,132,.5);color:#fff}.u-button--full-width{display:flex;width:100%}.u-clearfix:after,.u-clearfix:before{content:"";display:table}.u-clearfix:after{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-display-flex{display:flex;width:100%}.u-align-items-center{align-items:center}.u-justify-content-space-between{justify-content:space-between}.u-flex-static{flex:0 0 auto}.u-display-none{display:none}.js .u-js-hide{display:none;visibility:hidden}.u-show{display:block;visibility:visible}@media print{.u-hide-print{display:none}}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-position-relative{position:relative}.u-mt-16{margin-top:16px}.u-mt-32{margin-top:32px}.u-mr-24{margin-right:24px}.u-mr-48{margin-right:48px}.u-mb-32{margin-bottom:32px}.u-ml-8{margin-left:8px}.u-button-reset{background-color:transparent;border:0;padding:0}.u-text-sm{font-size:14px}.u-h3,.u-h4{color:#1b3051;font-family:-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Oxygen-Sans,Ubuntu,Cantarell,Helvetica Neue,sans-serif;font-size:18px;font-style:normal;line-height:1.4;margin-bottom:.7em}.u-h4{font-style:italic;font-weight:700}.u-vh-full{min-height:100vh}.u-hide{display:none;visibility:hidden}@media only screen and (min-width:1024px){.u-hide-at-lg{display:none;visibility:hidden}}@media only screen and (max-width:1023px){.u-hide-at-lt-lg{display:none

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 17, 2026. Paragraph numbers are ours, so an answer can point at one.

1Even though it can meet the ARDS Berlin definition, the COVID-19 pneumonia is a specific disease with peculiar phenotypes. Its main characteristic is the dissociation between the severity of the hypoxemia and the maintenance of relatively good respiratory mechanics. Indeed, the median respiratory system compliance is usually around 50 ml/cmH2O. Of note, the patients with respiratory compliance lower or higher than the median value experience hypoxemia of similar severity. We propose the presence of two types of patients (“non-ARDS,” type 1, and ARDS, type 2) with different pathophysiology. When presenting at the hospital, type 1 and type 2 patients are clearly distinguishable by CT scan (Fig. 1). If the CT scan is not available, the respiratory system compliance and possibly the response to PEEP are the only imperfect surrogates we may suggest.

Type 1: Near normal pulmonary compliance with isolated viral pneumonia

2In these patients, severe hypoxemia is associated with respiratory system compliance > 50 ml/cmH2O. The lung’s gas volume is high, the recruitability is minimal, and the hypoxemia is likely due to the loss of hypoxic pulmonary vasoconstriction and impaired regulation of pulmonary blood flow. Therefore, severe hypoxemia is primarily due to ventilation/perfusion (VA/Q) mismatch. High PEEP and prone positioning do not improve oxygenation through recruitment of collapsed areas, but redistribute pulmonary perfusion, improving the VA/Q relationship. Lung CT scans in those patients confirm that there are no significant areas to recruit, but the right-to-left venous admixture is typically around 50%.

Type 2: Decreased pulmonary compliance

3In 20–30% of these COVID-19 patients admitted to the intensive care unit (ICU), severe hypoxemia is associated with compliance values < 40 ml/cmH2O, indicating severe ARDS. It is certainly possible that their lower compliance (i.e., lower gas volume and increased recruitability) is due to the natural evolution of the disease, but we cannot exclude the possibility that this severity of damage (increased edema) results in part from the initial respiratory management. Indeed, some of these hypoxemic patients receive CPAP or non-invasive ventilation before ICU admission and present with very high respiratory drives, vigorous inspiratory efforts, and highly negative intrathoracic pressures. Therefore, in addition to viral pneumonia, those patients likely have self-inflicted ventilator-induced lung injury.

Before ICU, in non-intubated patients

4CPAP and NIV are the first-line treatment when an overwhelming number of patients come to a hospital. These interventions, often applied outside the ICU in emergency rooms or in other medicine wards, usually improve blood oxygenation. A key aspect of care, however, should be the assessment of respiratory drive and the inspiratory efforts. The ideal indicator would be the measurement of the esophageal pressure swings. If impossible, the clinical signs of inspiratory efforts should be carefully scrutinized. If respiratory distress is present, endotracheal intubation should be strongly considered to avoid/limit the transition from type 1 to type 2 by self-induced lung injury.

Tidal volume

5In type 2 patients, a lower tidal volume should be applied. However, type 1 patients lack the low compliance/high driving pressure prerequisites of ventilator-induced lung injury, even if treated with volumes higher than 6 ml/kg delivered at respiratory rates of 15–20 breaths/min. More liberal tidal volume (7–8 ml/kg) often attenuates dyspnea and may avoid hypoventilation with possible reabsorption atelectasis and hypercapnia.

PEEP

6The type 1 patients lack the prerequisite for higher PEEP to work (recruitability). PEEP levels should be limited at 8–10 cmH2O, since higher levels will decrease pulmonary compliance and can impact right heart function. The type 2 patients are characterized by a reduction of total gas volume and an increase in lung weight and edema. These features may be due to the natural progression of the disease, to bacterial superinfection and/or to self-induced lung injury during the period preceding the intubation. In these patients, a cautious gradual increase of PEEP up to 14–15 cmH2O may be beneficial. A decrease in SvO2 during this phase suggests an inadequate cardiac output so that higher PEEP levels for lung recruitment may no longer be useful. Cardiac ultrasound may also be useful for assessing right heart function when increasing PEEP levels.

Shunt determination

7Calculating the shunt fraction is the best tool to assess oxygenation.

8The etCO2/PaCO2 relationship is a useful tool to quantify efficiency of pulmonary exchange. A ratio < 1 suggests elevated shunt and dead space (areas of lung ventilated and not perfused).

Prone positioning

9For type 2 patients, prone position could be used as a long-term treatment—as in any form of severe ARDS. However, in type 1 patients, prone positioning should be considered more as a rescue maneuver to facilitate the redistribution of pulmonary blood flow, rather than for opening collapsed areas. Long-term prone positioning/supine cycles is of very little benefit in patients with high lung compliance, and it leads to high levels of stress and fatigue in the personnel.

Nitric oxide

10The oxygenation response to NO is variable. The COVID-19 pneumonia appears to interfere with the vascular regulation up to complete loss of vascular tone to vasoconstricting or vasodilating agents. We still do not have enough evidence to understand when and on which patients it should be applied. Nitric oxide should not work in fully vasoplegic patients (type 1 in our model) but possibly works in patients in which pulmonary hypertension is more likely (type 2 in our model).

(Micro)thrombosis and D-dimer levels

11In this disease, thrombosis and associated ischemic events are very common. A daily check of coagulation parameters, in particular D-dimer levels, should be performed in both the type 1 and the type 2 patients, judiciously anticoagulated when indicated.

12Type 1 patients: PEEP levels should be kept lower in patients with high pulmonary complianceTidal volume thresholds should not be limited at 6 ml/kgRespiratory rate should not exceed 20 breaths/minPatients should be left “quiet”; avoiding doing too much is of higher benefit than intervening at any cost.

13PEEP levels should be kept lower in patients with high pulmonary compliance

14Tidal volume thresholds should not be limited at 6 ml/kg

15Respiratory rate should not exceed 20 breaths/min

16Patients should be left “quiet”; avoiding doing too much is of higher benefit than intervening at any cost.

17Type 2 patients: Standard treatment for severe ARDS should be applied (lower tidal volume, prone positioning, and relatively high PEEP).

18Standard treatment for severe ARDS should be applied (lower tidal volume, prone positioning, and relatively high PEEP).

References 7

1.
Force* TADT: Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012;307(23):2526–33.
Not in our library10.1001/jama.2012.5669
2.
Force ARDSDT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012.
Not in our library10.1001/jama.2012.5669
3.
Maiolo G, Collino F, Vasques F, Rapetti F, Tonetti T, Romitti F, Cressoni M, Chiumello D, Moerer O, Herrmann P, et al. Reclassifying acute respiratory distress syndrome. Am J Respir Crit Care Med. 2018;197(12):1586-1595.
Not in our library10.1164/rccm.201709-1804oc
4.
Brochard L, Slutsky A, Pesenti A. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med. 2017;195(4):438-442.
Not in our library10.1164/rccm.201605-1081cp
5.
Acute Respiratory Distress Syndrome N, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-1308.
Not in our library10.1056/nejm200005043421801
6.
Gattinoni L, Taccone P, Carlesso E, Marini JJ. Prone position in acute respiratory distress syndrome. Rationale, indications, and limits. Am J Respir Crit Care Med. 2013;188(11):1286-1293.
Not in our library10.1164/rccm.201308-1532ci
7.
Guerin C, Reignier J, Richard JC. Prone positioning in the acute respiratory distress syndrome. N Engl J Med. 2013;369(10):980-981.
Not in our library10.1056/nejmc1308895

Cited by papers we hold 11

Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance · 2022
Not checked
The Role of Interleukin-8 in Lung Inflammation and Injury: Implications for the Management of COVID-19 and Hyperinflammatory Acute Respiratory Distress Syndrome · 2022
No notice
Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality · 2021
Not checked
The pulmonary pathology of COVID-19 · 2021
No notice
SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock · 2020
Not checked
A physiological approach to understand the role of respiratory effort in the progression of lung injury in SARS-CoV-2 infection · 2020
Not checked
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19 · 2020
No notice
The pathophysiology of ‘happy’ hypoxemia in COVID-19 · 2020
No notice
Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome · 2020
No notice
Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients · 2020
No notice
Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice · 2020
No notice

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.